Journal

Sublingual and Patch Immunotherapy for Food Allergy

Read time: 1 mins

Published:31st Jan 2020

Author: Waldron J, Kim EH.

Source: Immunology and Allergy Clinics of North America

Availability: Pay for access, or by subscription

Ref.:Immunol Allergy Clin North Am. 2020 Feb;40(1):135-148.

DOI:10.1016/j.iac.2019.09.008

Sublingual and Patch Immunotherapy for Food Allergy

This article reviews research advances for sublingual and patch immunotherapy for food allergy with a focus on peanut allergy. Published studies on sublingual immunotherapy (SLIT) and epicutaneous immunotherapy (EPIT) were summarized in this review. Sublingual and epicutaneous methods have emerged as alternatives to oral immunotherapy. SLIT studies have shown modest desensitization with a robust safety profile. EPIT studies have high adherence rates, an excellent safety profile, and potential for desensitization in children. Advances in food immunotherapy with SLIT and EPIT studies have shown promise as viable alternatives to oral immunotherapy for treatment of patients with peanut food allergy.

Read abstract on library site Access full article